Stockpolly
Search
Delisting risk
IVF · NASDAQ · Medical - Devices

INVO Fertility (IVF)

Operates fertility clinics and sells INVOcell for intravaginal culture.

$1.03
Pre-market+0.03 (+3.00%)
At close$1.00(−0.99%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue112212222222
Cost of revenue111111111112
Gross profit001101111111
122325322222
Research & development000000000000
Selling, general & administrative121323322222
Other expenses000001000000
Operating income−1−2−1−2−1−4−2−2−2−1−2−1
00−1000−15−2−13−42
Interest income000000000000
Interest expense000000000100
Other non-operating income00000−11511−440
Income before tax−1−2−2−2−2−4−17−3−32−61
Income tax expense000000000000
Net income from continuing operations−1−2−2−2−2−4−17−3−32−61
Discontinued operations0000000−20000
Net income−1−2−2−2−2−4−17−5−32−61
EPS, basic−$0.21−$1,157.73−$604.70−$895.62−$604.27−$1,268.18−$297.86−$209.79−$30.68$2.96−$3.38$0.42
EPS, diluted−$0.21−$1,157.73−$604.70−$895.62−$604.27−$1,268.18−$297.86−$209.79−$30.68$2.96−$3.38$0.34
Weighted average shares, basic600000000022
Weighted average shares, diluted600000000023
EBITDA−1−2−1−2−1−3−17−3−23−5−1
Depreciation & amortization000000000000
EBIT−1−2−1−2−1−3−17−3−22−5−1